|Articles|August 1, 1996

July/August 1996
Volume 2
Issue 7

Breast Cancer Screening: Who, When, and How

Download PDF: Breast Cancer Screening: Who, When, and How

Articles in this issue

almost 30 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

almost 30 years ago

Article

Correspondence regarding, "Ethics in Managed Care: The Obligation of Administration to Attending Consequences"

almost 30 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

almost 30 years ago

Article

Understanding the Behavioral Response to Medical Innovation

almost 30 years ago

Article

Cost Comparison of Induction of Labor Versus Expectant Management in Pregnancies Lasting Longer Than 41 Weeks

almost 30 years ago

Article

Respiratory Syncytial Virus Immune Globulin: A Cost-Effectiveness Analysis

almost 30 years ago

Article

Improving Patient Satisfaction with Warfarin Management

almost 30 years ago

Article

The Third Generation of Managed Care

almost 30 years ago

Article

Results of a Smoking-Cessation Program in a Managed Care Setting

almost 30 years ago

Article

Formulary Decision-Making for Evolving Therapies -- A Case Example: Fluticasone and Asthma

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Breast Cancer Screening: Who, When, and How

Articles in this issue

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

Trending on AJMC

Special Report: The Oncology Care Model, 10 Years Later

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications

Long-Term Extension Data Support Durable Benefit of Rilzabrutinib in Persistent, Chronic ITP: David Kuter, MD, DPhil

Contributor: Turning Headwinds Into Momentum—How Value-Based Care Can Help Payers Manage Costs and Regain Stability

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox